Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

First European filing submission for multiple myeloma bispecific antibody

February 2, 2022 Research and Development

Janssen has announced the submission of a Marketing Authorisation Application (MAA) to the EMA, seeking approval for off-the-shelf-bispecific antibody teclistamab, …
News

FDA clearance of Investigational New Drug Application for novel peanut allergy vaccine

January 26, 2022 Research and Development

Allergy Therapeutics has announced the FDA clearance of the Investigational New Drug Application (IND) for its novel virus-like particle (VLP)-based …
News

Highest UK COVID-19 deaths since February as Pfizer begin trials for Omicron jab

January 26, 2022 Research and Development

Pfizer has begun clinical trials for its new COVID-19 vaccine tailored to the Omicron variant, and has shared that it …
News

Maxim Biomedical receives EUA for ClearDetect COVID-19 antigen home test

January 26, 2022 Research and Development

Maxim Biomedical have received an Emergency Use Authorisation (EUA) from the FDA for their new ClearDetect COVID-19 Antigen Home Test. …
News

New study highlights cell power as a functional biomarker for preventing tumour escape

January 26, 2022 Research and Development

LUMICKS announced that new research findings published in Translational Medicine detailed a novel design strategy for preventing tumour escape through …
News

Engitix and Dompé collaboration for fibrosis and cancer AI drug discovery

January 19, 2022 Research and Development

Engitix has announced the close of its $54m Series A financing, as well as a strategic collaboration, with Dompé farmaceutici …
News
e-6olmfwuay74lr

MHRA license Jyseleca for treatment of ulcerative colitis

January 19, 2022 Research and Development

Galapagos NV, the Belgian parent company of Galapagos Biotech Ltd, have announced that Jyseleca® (filgotinib 200mg tablets) has been granted …
News

UK launch of generic lenalidomide for myeloma

January 19, 2022 Research and Development

Accord Healthcare have announced the UK launch of generic lenalidomide, available for the treatment of adult patients with multiple myeloma, …
News

SMC accepts first-line treatment for lung cancer

January 19, 2022 Research and Development

The SMC has accepted AstraZeneca’s Tagrisso (osimertinib) for use as monotherapy for the first-line treatment of adult patients with locally …
News

White House announces plans to double COVID-19 tests for schools

January 12, 2022 Research and Development

The Biden administration announced new plans to increase COVID-19 protection in schools in the US, as the Omicron variant continues …
News

South Korea Ministry of Food and Drug Safety approves Novavax COVID-19 vaccine

January 12, 2022 Research and Development

Biotechnology company Novavax, alongside SK bioscience, a vaccine business subsidiary of Korea-based SK Group, announced that South Korea’s Ministry of …
News

WHO experts warn against repeated boosters as strategy against COVID-19

January 12, 2022 Research and Development

Repeating booster doses of the original COVID-19 vaccines is not a viable strategy against emerging variants, WHO has shared, predicting …
News

MHRA Approves Vertex’s Kaftrio combination with ivacaftor for Children With cystic fibrosis

January 12, 2022 Research and Development

Vertex Pharmaceuticals have announced the MHRA approval of the label extension of Kaftrio® (ivacaftor/tezacaftor/elexacaftor) in a combination regimen with ivacaftor, …
News

Bharat Biotech receives approval to test nasal COVID-19 shot as booster

January 5, 2022 Research and Development

India’s drug regulator has granted approval to Bharat Biotech, for late stage trials of its nasal COVID-19 vaccine to be …
News

FDA grants breakthrough therapy designation to novel EGFR inhibitor

January 5, 2022 Research and Development

The FDA has granted a  breakthrough therapy designation to Cullian Oncology’s CLN-081, in certain patients with locally advanced or metastatic …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025